Garrett Winslow insider trades: Damora Therapeutics (DMRA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Garrett reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | DMRA | ↓ Sell | 245 | $29.98 | $7K | Direct | Jul 7, 2026 (1d) |
| Jan 2, 2026 | GLTO | ↓ Sell | 255 | $21.38 | $5K | Direct | Jan 6, 2026 (4d) |
| Jul 3, 2025 | GLTO | ↓ Sell | 260 | $3.39 | $881 | Direct | Jul 8, 2025 (5d) |
| Jan 3, 2025 | GLTO | ↓ Sell | 471 | $5.60 | $3K | Direct | Jan 7, 2025 (4d) |
| Dec 3, 2021 | GLTO | ↑ Buy | 2,000 | $2.48 | $5K | Direct | Dec 6, 2021 (3d) |
| Jun 23, 2021 | GLTO | ↑ Buy | 2,000 | $4.80 | $10K | Direct | Jun 23, 2021 (0d) |
| Nov 20, 2020 | SBPH | ↓ Sell | 175 | $4.76 | $833 | Direct | Nov 23, 2020 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other DMRA insiders
Open-market trades in the last 12 months
About Garrett Winslow's insider trades
Garrett Winslow is General Counsel at Damora Therapeutics (DMRA). Since Nov 20, 2020, Garrett has reported 2 open-market purchases worth $15K and 5 sales worth $17K on SEC Form 4. In the last 12 months: 2 sales ($13K).
Their filings also include grants and awards (8 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DMRA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.